The propensity score analysis on the efficacy of sivelestat

Comment

Kentaro Iwata. Pulm Pharmacol Ther. 2013 Jun.

. 2013 Jun;26(3):395.

doi: 10.1016/j.pupt.2012.11.002. Epub 2012 Dec 4.

No abstract available

Comment in

The propensity score analysis on the efficacy of Sivelestat - author's reply.
Aikawa N. Aikawa N. Pulm Pharmacol Ther. 2013 Jun;26(3):396-7. doi: 10.1016/j.pupt.2013.02.005. Epub 2013 Feb 18. Pulm Pharmacol Ther. 2013. PMID: 23428647 No abstract available.

Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor, Sivelestat, for the treatment of acute lung injury associated with systemic inflammatory response syndrome; a phase IV study.
Aikawa N, Ishizaka A, Hirasawa H, Shimazaki S, Yamamoto Y, Sugimoto H, Shinozaki M, Taenaka N, Endo S, Ikeda T, Kawasaki Y. Aikawa N, et al. Pulm Pharmacol Ther. 2011 Oct;24(5):549-54. doi: 10.1016/j.pupt.2011.03.001. Epub 2011 Apr 22. Pulm Pharmacol Ther. 2011. PMID: 21540122 Clinical Trial.